Helix BioPharma announces CEO swap

Wednesday, March 30, 2016

Dr. Zbigniew Markowski has stepped down, for personal and family reasons, from his positions as chief executive officer of Helix BioPharma and chairman of Helix Polska. Helix BioPharma is a biopharmaceutical company developing innovative drug candidates for the prevention and treatment of cancer. Dr. Sven Rohmann will replace Markowski, effective immediately.

[Read More]